DACARBAZINE FOR INJECTION DIN 02566710
Health Canada record
| Active ingredient(s) | DACARBAZINE 500 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01AX04 DACARBAZINE |
| Original market date | |
| Current status date | 17-Mar-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sterimax Inc — licence 100925, currently licensed, last inspection rating C (2024-05-13).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing DACARBAZINE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02566702 | DACARBAZINE FOR INJECTION | STERIMAX INC | Powder For Solution | DACARBAZINE 200 MG | Approved |
| 02241445 | DACARBAZINE FOR INJECTION BP | PFIZER CANADA ULC | Powder For Solution | DACARBAZINE 600 MG | Marketed |
| 00521183 | DTIC DOME INJ 200MG/VIAL | MILES CANADA INC. - PHARMACEUTICAL DIVISION | Liquid | DACARBAZINE 200 MG | Cancelled Post Market |
| 02154854 | DTIC-DOME -PWS IV 200MG/VIAL | BAYER INC | Powder For Solution | DACARBAZINE 10 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 37124 | 2026-03-17 | Abbreviated New Drug Submission (ANDS) |
International API supply for DACARBAZINE
3 valid EDQM Certificates of Suitability from 3 holders. 3 active FDA Drug Master Files.
Request a quote for DACARBAZINE FOR INJECTION